Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Recruiting Not applicable

Development of a Pregnancy Weight Management Service Model

NCT07814885 · tracked via the Priya Life Science Taiwan tracker
Phase
Not applicable
Started
2025-12-01
Last updated
2026-09-11

Condition(s) studied

PregnancyWeight Gain

Investigational drug(s) / intervention(s)

Pregnancy Weight Management Counseling

Pregnancy Weight Management Counseling: Participants will receive in-person pregnancy weight management counseling provided by healthcare professionals. The counseling will provide individualized guidance on pregnancy weight management and related health behaviors according to participants' needs.

Study summary

To develop a pregnancy weight management application and service model for pregnant women, and to evaluate its feasibility and effects on gestational weight management and health behaviors during pregnancy.

Eligibility

Sex
FEMALE
Min age
20 Years
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: * Women older than 20 years. * Pregnant women with pregnancy confirmed by an obstetrician. * Singleton pregnancy. * Planning to deliver at the participating hospital. * Able to communicate in Mandarin Chinese or Taiwanese. * Have access to a smartphone, computer, or tablet. Exclusion Criteria: * No access to a smartphone, computer, or tablet.

Primary outcome measure(s)

  • Change in body weight — Baseline and after 8-12 weeks of intervention
    Body weight will be measured in kilograms before and after the pregnancy weight management intervention.
  • Change in technology acceptance — Baseline and after 8-12 weeks of intervention
    Technology acceptance will be assessed using the 23-item Technology Acceptance Model questionnaire. Each item is rated from 0 (strongly disagree) to 4 (strongly agree). Higher scores indicate greater acceptance of the pregnancy weight management application.

Trial sites (1)

FacilityCityRegionStatus
Mackay Memorial Hospital Taipei Taiwan Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07814885 on ClinicalTrials.gov ↗ ← All trials in Taiwan